Enanta Pharmaceuticals
ENTA
#8001
Rank
โ‚ฌ0.34 B
Marketcap
11,91ย โ‚ฌ
Share price
3.22%
Change (1 day)
113.82%
Change (1 year)

Enanta Pharmaceuticals (ENTA) - Net assets

Net assets on the balance sheet as of March 2026 : โ‚ฌ0.10 Billion

According to Enanta Pharmaceuticals 's latest financial reports the company has โ‚ฌ0.10 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Enanta Pharmaceuticals - Net assets on balance sheet (from 2011 to 2026)

Net assets by year

Year Net assets Change
2025-09-30$โ‚ฌ55.14 M-52.32%
2024-09-30$โ‚ฌ0.11 B-43.5%
2023-09-30$โ‚ฌ0.20 B-37.66%
2022-09-30$โ‚ฌ0.32 B-4.83%
2021-09-30$โ‚ฌ0.34 B-11.18%
2020-09-30$โ‚ฌ0.38 B-8.44%
2019-09-30$โ‚ฌ0.42 B25.09%
2018-09-30$โ‚ฌ0.33 B32.03%
2017-09-30$โ‚ฌ0.25 B6.68%
2016-09-30$โ‚ฌ0.24 B13.93%
2015-09-30$โ‚ฌ0.21 B79.57%
2014-09-30$โ‚ฌ0.11 B44.12%
2013-09-30$โ‚ฌ81.67 M138.15%
2012-09-30$โ‚ฌ34.29 M112.01%
2011-09-30$โ‚ฌ16.17 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ70.24 B 69,535.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ33.67 B 33,288.80%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
-โ‚ฌ5.73 Billion-5,771.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
โ‚ฌ16.75 B 16,507.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ39.73 B 39,296.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ17.39 B 17,142.06%๐Ÿ‡บ๐Ÿ‡ธ USA